Whether solid organ transplant (SOT) recipients are at increased risk of poor outcomes due
to COVID‐19 in comparison to the general population remains uncertain. In this study, we …

Immunosuppression and comorbidities might place solid organ transplant (SOT) recipients
at higher risk from COVID-19, as suggested by recent case series. We compared 45 SOT vs …

Background Solid‐organ transplant (SOT) recipients with coronavirus disease 2019 (COVID‐
19) have higher risk of adverse outcomes compared to the general population. Whether …

Data describing outcomes of solid organ transplant (SOT) recipients with coronavirus
disease 2019 (COVID‐19) are variable, and the association between SOT status and …

Background The COVID‐19 pandemic has caused significant morbidity and mortality in solid
organ transplant (SOT) recipients. However, it remains unclear whether the risk factor for …

We compared the outcome of COVID‐19 in immunosuppressed solid organ transplant (SOT)
patients to a transplant naïve population. In total, 10 356 adult hospital admissions for …

In the context of COVID-19 pandemic, we aimed to analyze the epidemiology, clinical
characteristics, risk factors for mortality and impact of COVID-19 on outcomes of solid organ …

Background. Solid organ transplant (SOT) recipients are considered to be “vulnerable” to
COVID-19 infection due to immunosuppression. To date, there are no studies that compared …

Background. Organ transplant recipients comprise an immunocompromised and vulnerable
cohort. Outcomes of coronavirus disease 2019 (COVID-19) in solid organ transplant (SOT) …

Abstract Coronavirus disease 2019 (COVID‐19) may be associated with worse outcome in
solid organ transplant (SOT) recipients. We performed a prospective cohort study of …